HTLV: un nou subiect pentru screeningul prenatal?
Authors:
- Alina-Irina AnghelAAAlina-Irina Anghel
- Cristiana-Elena DurduCDCristiana-Elena Durdu
- Roxana-Elena BohîlţeaRBRoxana-Elena Bohîlţea
Open Access
- 28 March 2024
- journal article
- research article
- Published by MedicHub Media in Ginecologia.ro
- Vol. 1 (1) , 22-24
Abstract
Human T-cell leukemia virus-1 (HTLV-1) is the first infectious agent proven to cause cancer, and it is considered among the most potent carcinogens for humans. HTLV-1 is estimated to have infected 5-10 million individuals, with only about 5% of people that contract the virus expected to develop any associated disease. Within Europe, Romania appears to be the only region endemic to HTLV-1. There are two primary diseases associated with HTLV-1, T-cell leukemia/lymphoma (ATL) and HTLV-1-associated myelopathy (HAM), or tropical spastic paraparesis (TSP). Each is linked to a distinct mode of transmission: ATL with breastfeeding, and HAM/TSP with blood transfusion. The main ways of viral transmission are from mother to child by breastfeeding, via blood transfusions, or through sexual intercourse. Vertical infection rate has been found to be 14.2%. In Romania, HTLV is included in the screening for blood donors, but not in prenatal screenings. Vertically transmitted infections can be reduced with up to 87% by avoiding breastfeeding. New research supports the effectiveness of prenatal screening followed by avoiding breastfeeding in reducing new cases of HTLV in endemic areas, and such measures must be taken in Romania as well.Keywords
This publication has 20 references indexed in Scilit:
- Screening for HTLV-1 infection should be expanded in EuropeInternational Journal of Infectious Diseases, 2024
- Monitoring of HTLV-1-associated diseases by proviral load quantification using multiplex real-time PCRJournal of NeuroVirology, 2022
- Risk factors associated with HTLV-1 vertical transmission in Brazil: longer breastfeeding, higher maternal proviral load and previous HTLV-1-infected offspringScientific Reports, 2018
- Clinical Characteristics of Patients in Peru with Human T Cell Lymphotropic Virus Type 1–Associated Tropical Spastic ParaparesisClinical Infectious Diseases, 2004
- Effect of Human T-Lymphotropic Virus Type I Infection on Non-Hodgkin's Lymphoma IncidenceJNCI: Journal of the National Cancer Institute, 1995
- Heterosexual Transmission of Human T Cell Leukemia/Lymphoma Virus Type I among Married Couples in Southwestern Japan: An Initial Report from the Miyazaki Cohort StudyThe Journal of Infectious Diseases, 1993
- A prospective study of transmission by transfusion of HTLV‐I and risk factors associated with seroconversionInternational Journal of Cancer, 1992
- Evaluation of enzyme immunoassays for antibody to human T-lymphotropic viruses type I/IIThe Lancet, 1991
- ANTIBODIES TO HUMAN T-LYMPHOTROPIC VIRUS TYPE-I IN PATIENTS WITH TROPICAL SPASTIC PARAPARESISThe Lancet, 1985
- Isolation and characterization of retrovirus from cell lines of human adult T-cell leukemia and its implication in the disease.Proceedings of the National Academy of Sciences, 1982